Valuation: Ipsen

Market Cap 13.63B 15.54B 12.58B 11.63B 22.04B 1,488B 22.48B 151B 58.77B 728B 58.35B 57.07B 2,527B P/E 2026 *
15.1x
P/E 2027 * 14.8x
Enterprise Value 12.21B 13.92B 11.27B 10.41B 19.74B 1,333B 20.13B 135B 52.64B 652B 52.26B 51.12B 2,264B EV / Sales 2026 *
2.86x
EV / Sales 2027 * 2.5x
Free-Float
40.65%
Yield 2026 *
0.91%
Yield 2027 * 0.9%
1 day-1.43%
1 week-1.66%
Current month-1.66%
1 month+5.20%
3 months+1.28%
6 months+36.40%
Current year+39.50%
1 week 164.9
Extreme 164.9
172.7
1 month 152.7
Extreme 152.7
172.7
Current year 116
Extreme 116
173.5
1 year 101.6
Extreme 101.6
173.5
3 years 87.95
Extreme 87.95
173.5
5 years 77
Extreme 77
173.5
10 years 34.2
Extreme 34.2
173.5
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2020
Chief Executive Officer 57 01/01/2020
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 30/08/2005
Chairman 68 22/11/2010
Director/Board Member 69 01/06/2012
Date Insider Type Main position Quantity % Market Cap.
06-01Fiscal year

Chief Executive Officer

-26,583 0.0317%
05-27Sell

Chief Executive Officer

-1,000 0.0012%
02-25Sell

Chairman

3,800 0.0045%
Change 5-day change 1-year change 3-year change Capi.($)
-1.43%-1.66%+61.95%+53.28% 15.8B
-1.60%+2.02%+56.34%+168.30% 1,102B
-1.44%+3.71%+69.07%+65.13% 643B
-0.75%+0.67%+33.18%+87.92% 450B
-1.35%+1.86%+29.96%+26.26% 336B
-0.71%+0.72%+28.85%+46.77% 288B
-1.31%-0.26%-28.18%-39.13% 222B
-0.03%+1.84%+23.90%+63.75% 199B
-0.40%+7.82%+22.29%+79.44% 169B
-0.08%+0.71%-6.13%-32.60% 137B
Average -0.86%+2.01%+29.12%+51.91% 356.09B
Weighted average by Cap. -1.09%+2.06%+39.94%+85.08%

Financials

2026 *2027 *
Net sales 4.27B 4.87B 3.94B 3.64B 6.91B 466B 7.04B 47.4B 18.42B 228B 18.28B 17.88B 792B 4.49B 5.12B 4.14B 3.83B 7.26B 490B 7.4B 49.83B 19.36B 240B 19.22B 18.8B 833B
Net income 940M 1.07B 868M 802M 1.52B 103B 1.55B 10.43B 4.05B 50.2B 4.02B 3.94B 174B 949M 1.08B 876M 809M 1.53B 104B 1.56B 10.53B 4.09B 50.67B 4.06B 3.97B 176B
Net Debt -1.42B -1.62B -1.31B -1.21B -2.3B -155B -2.35B -15.79B -6.13B -75.99B -6.09B -5.96B -264B -2.42B -2.76B -2.24B -2.07B -3.92B -264B -3.99B -26.88B -10.44B -129B -10.37B -10.14B -449B
Logo Ipsen
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows: - oncology (69.2%); - neuroscience (20.3%); - rare diseases (10.5%). At the end of 2025, the group had 7 research and development centers located in France (2), the United Kingdom (2), China (2) and Ireland, and 5 manufacturing sites worldwide. Net sales are distributed geographically as follows: France (8%), Europe (31.7%), the United States (32.9%), North America (2.2%) and other (25.2%).
Employees
5,535
Date Price Change Volume
08/07/26 166.00 -1.43% 140,827
07/07/26 €168.40 -0.65% 97,562
06/07/26 €169.50 -0.70% 80,079
03/07/26 €170.70 -0.23% 68,410
02/07/26 €171.10 +3.20% 134,415
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
168.40EUR
Average target price
161.33EUR
Spread / Average Target
-4.20%

Quarterly revenue - Rate of surprise